Performances in N.Y.C. Advertisement Supported by The show about the country music queen, “Dolly: A True Original Musical,” will begin performances on Broadway in December. By Michael Paulson See more ...
A West End production has the hits, and Joel Harper-Jackson brings swagger and style to the leading role. But where’s the pizazz? By Matt Wolf Reviewing from London “Come fly with me,” a young Frank ...
‘DOLLY: A True Original Musical’ will open at the St. James Theatre in New York City on Jan. 19, 2027, Parton’s 81st birthday Jeff Kravitz/FilmMagic Broadway audiences will soon be saying “Hello, ...
Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Among all the awards and mementos Moderna ...
Moderna has unveiled its first in vivo CAR-T program. Building on other groups’ ex vivo CAR-T data, the company plans to start clinical development of an off-the-shelf autoimmune disease prospect, ...
At its latest R&D update, Moderna revealed a move into the pioneering in vivo CAR-T category, adding another treatment class to its R&D capabilities. It has nominated a lead candidate in the in vivo ...
MRNA surged 14%, dwarfing the 2% gains of MRK and PFE, driven by an FDA flu vaccine endorsement and a blowout Q1 revenue beat. Despite MRNA's 130% YTD surge, Wall Street's consensus target of $43 sits ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Moderna (MRNA) announced the appointment of Michael McDonnell to its Board of Directors, effective July 8, 2026. He will also join the board's audit committee. McDonnell brings more than three decades ...
Moderna Inc. Chief Executive Officer Stephane Bancel said he sees the pending launch of a planned flu vaccine as a chance to start a public conversation about how mRNA technology can offer better ...
On June 18, Moderna disclosed how a Food and Drug Administration (FDA) advisory committee voted unanimously that the benefits of its mRNA-based flu vaccine, mRNA-1010, outweigh the risks among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results